Detection of locally recurrent colorectal cancer with radiolabeled monoclonal antibody H-15.

Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.

Perioperative radioimmunolocalization of colorectal cancer by radiolabeled monoclonal antibodies.

Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody.

Detection of primary colorectal cancer with indium 111 monoclonal antibody B72.3.

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.

Tumor localization and biodistribution with radiolabeled monoclonal antibody against pancreatic cancer in tumor-bearing nude mice.

Evaluation of a technique for the intraoperative detection of a radiolabelled monoclonal antibody against colorectal cancer.

Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column.

Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.

Radiolabeled antibody imaging in the management of colorectal cancer. Results of a multicenter clinical study.

Colorectal carcinoma metastases: detection with In-111-labeled monoclonal antibody CCR 086.

Biodistribution of radiolabeled monoclonal antibody after intraperitoneal administration in nude mice with hepatic metastasis from human colon cancer.

Postmastectomy locally recurrent breast cancer.

Clinical review: surgical management of locally advanced and recurrent colorectal cancer.

Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer.

Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patients.

SPECT anti-CEA monoclonal antibody detection of occult colorectal carcinoma metastases.

$Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase alpha.$
Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase alpha.

Monoclonal antibody therapy of cancer.

Tumor-specific binding of radiolabeled G-22 monoclonal antibody in glioma patients.

Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience.

Cancer imaging with radiolabeled antibodies.

Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.

FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer.

Suggest Documents

Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.

Perioperative radioimmunolocalization of colorectal cancer by radiolabeled monoclonal antibodies.

Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody.

Detection of primary colorectal cancer with indium 111 monoclonal antibody B72.3.

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.

Tumor localization and biodistribution with radiolabeled monoclonal antibody against pancreatic cancer in tumor-bearing nude mice.

Evaluation of a technique for the intraoperative detection of a radiolabelled monoclonal antibody against colorectal cancer.

Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column.

Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.

Radiolabeled antibody imaging in the management of colorectal cancer. Results of a multicenter clinical study.

Colorectal carcinoma metastases: detection with In-111-labeled monoclonal antibody CCR 086.

Biodistribution of radiolabeled monoclonal antibody after intraperitoneal administration in nude mice with hepatic metastasis from human colon cancer.

Postmastectomy locally recurrent breast cancer.

Clinical review: surgical management of locally advanced and recurrent colorectal cancer.

Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer.

Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patients.

SPECT anti-CEA monoclonal antibody detection of occult colorectal carcinoma metastases.

Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase alpha.

Monoclonal antibody therapy of cancer.

Tumor-specific binding of radiolabeled G-22 monoclonal antibody in glioma patients.

Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience.

Cancer imaging with radiolabeled antibodies.

Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.

FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer.

Detection of locally recurrent colorectal cancer with radiolabeled monoclonal antibody H-15.

Recommend Documents

Follow Us